Cannabis use can shift several common blood test values, sometimes enough to push results outside normal reference ranges or confuse a diagnosis. The effects span white blood cell counts, hemoglobin, liver enzymes, insulin, stress hormones, inflammatory markers, and even heavy metal levels. Most shifts are modest in occasional users, but heavy or daily use produces changes that doctors and patients should know about, especially if bloodwork is being used to investigate a new symptom or monitor a chronic condition.
White Blood Cells and Hemoglobin
A complete blood count is one of the most frequently ordered lab tests, and cannabis can nudge several of its components. A large analysis using U.S. national survey data found that heavy cannabis users had a meaningfully higher total white blood cell count compared with people who had never used it, driven mainly by a bump in neutrophils, which are the immune cells that respond first to infection or injury.1PubMed Central. Total and differential white blood cell count in cannabis users: results from the cross-sectional National Health and Nutrition Examination Survey, 2005–2016 A separate study of psychiatric inpatients confirmed that those who tested positive for cannabinoids had higher white cells across several subtypes, with the neutrophil increase especially pronounced among patients with psychotic disorders.2Brain, Behavior, & Immunity – Health. Differences in total and differential white blood cell counts and in inflammatory parameters between psychiatric inpatients with and without recent consumption of cannabinoids, opioids, or cocaine Occasional or former users, by contrast, did not show the same pattern, suggesting the effect is tied to how much and how recently you use.
Hemoglobin tells a different story depending on who is measuring it and where. An analysis of the same national survey data from 2009 to 2018 found that current cannabis users had slightly higher hemoglobin concentrations than people who had never used, by roughly 0.1 g/dL after adjusting for other factors.3PubMed. Marijuana Use and Hemoglobin Concentrations in NHANES 2009-2018: Implications for Subclinical Hypoxemia The researchers speculated this could reflect a compensatory response to mild, chronic drops in blood oxygen from inhaling smoke, similar to what happens at high altitude. A smaller study from Morocco, however, found the opposite direction in heavy hashish smokers, reporting decreases in hemoglobin, red blood cells, and hematocrit alongside a longer duration and heavier volume of use.4AIMS Medical Science. The effects of smoking Haschich on blood parameters in young people from the Beni Mellal region Morocco The discrepancy probably reflects differences in study populations, the cannabis products involved, and how confounders like nutrition and tobacco co-use were handled. The practical takeaway: if your hemoglobin is borderline high or borderline low, cannabis use is worth mentioning to your doctor so they can interpret the number in context.
Platelets and Clotting
Platelets are the blood cells responsible for clotting, and cannabinoids interact with them in ways that could matter if you are headed into surgery or already on blood thinners. Research in nonhuman primates given daily THC edibles showed reduced platelet stickiness, aggregation, and the chemical signaling platelets use to form clots.5PubMed Central. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in nonhuman primates reduces systemic platelet activity and function A pilot study looking directly at human platelets exposed to cannabis extract found a similar pattern: initial activation followed by impaired aggregation when the platelets were challenged by standard clotting triggers like collagen and ADP.6PubMed. Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine Laboratory work on CBD and CBG (another cannabinoid) separately confirmed that both compounds reduce platelet aggregation and clot formation on collagen-coated surfaces, even at concentrations that are not toxic to the cells.7CentAUR. The effects of phytocannabinoids cannabidiol and cannabigerol on platelet modulation, thrombus formation and inflammatory responses
On a standard CBC, these changes might not show up as an abnormal platelet count, because the issue is with how platelets function, not how many of them are circulating. That distinction matters: a surgeon reviewing your bloodwork before a procedure would see a normal platelet number and might not suspect that the cells are less effective at forming clots. If you use cannabis regularly and you have an upcoming procedure, flagging that for your care team lets them consider platelet function testing or adjust their surgical prep.
Liver Enzymes
The liver enzyme markers AST and ALT are part of the standard metabolic panel. Elevated levels prompt doctors to investigate liver damage, medication toxicity, or hepatitis. A case-control study of cannabis-only users found that average AST was roughly double the control group’s level, and groups using THC alongside other substances also showed elevated ALT.8PubMed. Impact of cannabis, benzodiazepines, and methamphetamine use on inflammatory and hepatic biomarkers in Benin City, Nigeria: a case-control study The Moroccan hashish study mentioned earlier also reported decreases in SGOT and SGPT (older names for the same enzymes) with longer-term heavy use, which may reflect a different trajectory over time or differences in the products consumed.4AIMS Medical Science. The effects of smoking Haschich on blood parameters in young people from the Beni Mellal region Morocco
What this means practically is that a mildly elevated AST on routine bloodwork could be chalked up to cannabis use rather than triggering an expensive workup for liver disease. But it also means regular heavy use might genuinely be stressing the liver. The safest approach is to be upfront with your doctor about cannabis use so they can weigh the enzyme bump appropriately rather than ordering unnecessary imaging or a hepatitis panel.
Kidney Function
Kidney markers on a standard metabolic panel include creatinine and estimated glomerular filtration rate (eGFR), and here the news is fairly reassuring. A study using national survey data found no significant link between cannabis use and creatinine, eGFR, or the odds of having chronic kidney disease.9PubMed. Marijuana Use and Renal Function Among US Adults A more recent longitudinal study tracked kidney outcomes over time and found that regular cannabis users were not at higher risk for developing chronic kidney disease, rapid kidney function decline, or protein leaking into urine.10PubMed. Evaluating the Association of Cannabis Use and Longitudinal Kidney Outcomes So if you are worried that cannabis use will make your kidney numbers look bad on a standard blood panel, the existing evidence suggests it probably will not.
Blood Sugar and Insulin
One of the more surprising and consistently replicated findings involves fasting insulin. A well-known analysis of U.S. adults found that current cannabis users had about 16% lower fasting insulin and 17% lower insulin resistance (measured by the standard HOMA-IR index) compared with non-users.11PubMed. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults A study in an Inuit population found a similar pattern: cannabis users had lower fasting insulin and lower insulin resistance, though much of the effect appeared to work indirectly through lower body mass index.12PubMed. Cannabis use in relation to obesity and insulin resistance in the Inuit population
Before you conclude that cannabis is protective against diabetes, there are complications. A study that looked more carefully at insulin secretion found no significant differences in insulin sensitivity between regular users and non-users, but did find that regular users had a higher early insulin secretion response to a glucose challenge.13PubMed Central. Associations Between Cannabis Use, Abdominal Fat Phenotypes and Insulin Traits That is a different thing from better metabolic health: it may simply mean the pancreas is working harder. And the lower BMI that seems to mediate the insulin findings could reflect appetite changes, lifestyle patterns, or other factors that travel alongside cannabis use rather than being caused by it.
As for lipids, a study in Black adults found that current cannabis users tended toward lower total cholesterol, LDL, and triglycerides compared with non-users, but none of these differences reached statistical significance.14PubMed Central. Metabolic Effects of Marijuana Use Among Blacks So while cannabis might slightly shift these numbers, the effects are small and inconsistent enough that they are unlikely to alter a cholesterol-management decision on their own.
Cortisol, Testosterone, and Thyroid Hormones
Cannabis has clear, dose-dependent effects on cortisol, the body’s main stress hormone. Acute THC raises cortisol levels, but frequent users develop a blunted response: their cortisol spikes less with each dose and they also show dampened cortisol reactions to everyday stressors.15Frontiers in Psychiatry. Marijuana Use and Hypothalamic-Pituitary-Adrenal Axis Functioning in Humans Controlled dosing studies have confirmed this tolerance effect, with heavy users showing a muted cortisol rise compared with occasional users given the same amount of THC.16PubMed Central. The effects of cannabinoids on serum cortisol and prolactin in humans If your doctor orders a cortisol test to investigate fatigue, weight changes, or suspected adrenal problems, recent cannabis use could produce a misleadingly normal or low reading in a heavy user, or a falsely elevated one in a new user.
Testosterone is a common concern among male cannabis users, and the data is more reassuring than many expect. A large U.S. study found essentially no difference in serum testosterone between men who had ever used cannabis and those who had never used it. What did matter was recency: men who had used very recently tended to have slightly higher testosterone, and the further out from last use, the lower the levels trended, especially in men aged 18 to 29.17PubMed Central. Marijuana use and serum testosterone concentrations among U.S. males A study of young Swiss men found that cannabis users had higher levels of several androgens, estradiol, and sex hormone-binding globulin, with no significant changes in the gonadotropins (LH and FSH) that drive testosterone production.18PubMed. Gonadotropin axis and semen quality in young Swiss men after cannabis consumption: Effect of chronicity and modulation by cannabidiol The picture is complex, but the old idea that weed tanks your testosterone does not hold up well in modern population-level data.
Thyroid hormones are another area with mixed signals. One analysis of national survey data found that recent cannabis users were less likely to have elevated TSH, the hormone that rises when the thyroid is underperforming.19PubMed. Effect of Marijuana Use on Thyroid Function and Autoimmunity A separate study focused on men with psychiatric conditions found no significant impact of cannabis on TSH, T3, or T4.20Frontiers in Psychiatry. Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population The thyroid effects, if they exist, appear minor and are unlikely to produce a false diagnosis on their own, but they add to the general picture that cannabis touches a surprising number of hormonal dials.
Inflammation Markers
C-reactive protein (CRP) is a go-to marker when doctors want to gauge systemic inflammation, and cannabis users consistently show lower levels. A study of U.S. adults found that past-30-day cannabis use was associated with lower high-sensitivity CRP even after adjusting for BMI and other confounders.21PubMed Central. Self-reported cannabis use and biomarkers of inflammation among adults in the United States An earlier analysis using national survey data from 2005 to 2010 found the same direction: recently active cannabis users had generally lower CRP than people who had never used, with the effect most evident in the lower half of CRP values.22PubMed Central. Cannabis Smoking and Serum C-Reactive Protein: A Quantile Regressions Approach Based on NHANES 2005–2010
A longer-term cohort study (the CARDIA study, which follows young adults into middle age) added nuance. After adjusting for confounders, recent cannabis use was not significantly associated with CRP, IL-6, or fibrinogen.23PubMed Central. Cannabis Use and Markers of Systemic Inflammation: The Coronary Artery Risk Development in Young Adults Study Former use, interestingly, was linked to lower fibrinogen. The discrepancies across studies likely come down to timing, how heavy the use is, and whether the study adjusted for every relevant confounder. The general trend leans toward lower CRP in active users, which could mask inflammation that a doctor is trying to detect or could reflect genuine immunomodulatory effects of cannabinoids. Either way, it is a wrinkle worth knowing about if you are getting inflammatory markers tested for a specific clinical reason.
Heavy Metals in Your Bloodstream
This one catches people off guard. A large analysis of exclusive marijuana users (no tobacco) found higher blood cadmium and lead levels compared with people who used neither substance. Exclusive marijuana users had roughly 22% higher blood cadmium and 27% higher blood lead, with urinary cadmium confirming the pattern.24PubMed Central. Blood and Urinary Metal Levels among Exclusive Marijuana Users in NHANES (2005–2018) Cannabis plants are efficient at pulling heavy metals from soil, a trait called hyperaccumulation, and combustion concentrates those metals in smoke. A comparative study of drug users confirmed significantly higher concentrations of arsenic, cadmium, mercury, and nickel in biological samples from people using cannabinoid products.25PubMed. Determination of Toxic Elements in Cannabinoid and Opioid Drugs and Their Impact on Addicts’ Health: A Comparative Study
Heavy metal levels do not usually show up on routine bloodwork because doctors do not order them without specific suspicion. But if you are getting tested for occupational exposure, environmental contamination, or unexplained symptoms that prompt a heavy metal panel, cannabis use could be the unsuspected source. This is also one area where the product’s origin matters enormously: cannabis grown in contaminated soil or with unregulated fertilizers will carry far more metals than product from a tested, legal supply chain.
How Consumption Method Changes the Picture
Smoking and eating cannabis are not interchangeable when it comes to blood test effects. A recent study directly compared marijuana smokers, THC-edible users, and non-users. The smokers showed significantly impaired endothelial function, as measured by how their blood serum affected nitric oxide production in lab-grown blood vessel cells. Edible users, by contrast, were indistinguishable from non-users on that same measure.26JAMA Cardiology. Association of Endothelial Dysfunction With Chronic Marijuana Smoking and THC-Edible Use The heavy metal exposure discussed above is also primarily a combustion issue: switching to edibles, tinctures, or vaporizers that heat below combustion temperatures would reduce metal intake substantially.
THC itself behaves differently in the bloodstream depending on route. After smoking, blood THC peaks within minutes and drops fast: occasional users fell below a 5 microgram-per-liter threshold in about an hour on average, while frequent smokers stayed above it for a median of about three and a half hours, with some exceeding 30 hours.27Clinical Chemistry. Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis Edibles produce a slower, flatter curve with lower peak blood levels but longer duration. These pharmacokinetic differences affect not only drug testing but also how long cannabinoids are interacting with enzymes, receptors, and blood cells.
Drug Interactions That Can Skew Other Medications’ Levels
If you take prescription medications and you are getting blood levels checked for those medications, cannabis could be a hidden confounder. THC is broken down by two liver enzymes (CYP3A4 and CYP2C9) that also metabolize a wide range of common drugs, including certain blood thinners, anti-seizure medications, and immunosuppressants. Cannabis use can alter the activity of these enzymes, potentially raising or lowering the blood levels of other drugs you are taking.28PubMed Central. Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions Genetic variation in CYP2C9 adds another layer: up to about a third of people of European descent carry a variant that slows THC metabolism, meaning THC hangs around longer and has more time to interfere with other drug processing. If your therapeutic drug levels come back unexpectedly high or low, cannabis use is one of the variables worth considering.
Vitamin D and Nutritional Markers
Frequent cannabis users have been found to have lower vitamin D levels. A study of people with severe substance use disorders in Norway found that frequent cannabis consumers had serum vitamin D concentrations about 5 nmol/L lower than those with less or no use.29Scientific Reports. Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway Whether that reflects a direct biological effect of cannabis or the lifestyle factors that tend to accompany heavy use (spending more time indoors, different dietary patterns) is unclear. Case reports have also documented low vitamin B12 and elevated homocysteine in cannabis users, a combination that can contribute to fatigue and neurological symptoms.30Journal of Chiropractic Medicine. Management of Hyperhomocysteinemia, Low Vitamin Levels, and Low Cortisol in Cannabis Users: A Report of 2 Cases These are not dramatic shifts, but if you are investigating persistent tiredness or mood changes and your doctor checks micronutrients, cannabis use is a relevant piece of the puzzle.
When Rare but Dramatic Results Show Up
Most cannabis-related blood test changes are subtle enough that a doctor would describe them as “within the noise” or “borderline.” But occasionally, cannabis use produces results that look alarming. One case report described a young adult presenting with chest pain after heavy cannabis use whose troponin level, the cardiac enzyme used to diagnose heart attacks, spiked to over 1,200 ng/mL during admission.31PubMed Central. A Case Report of Cannabis Abuse: A Surprising Etiology of Elevated Troponin Cannabis-induced coronary vasospasm, where the arteries supplying the heart temporarily clamp down, is thought to be the mechanism. Cases like this are rare, but they illustrate why emergency physicians increasingly ask about cannabis use when cardiac enzymes come back elevated in a young person without typical risk factors.
The broader lesson here is that cannabis affects enough blood markers across enough body systems that treating it as invisible to lab work is a mistake. You do not need to panic about routine bloodwork if you use cannabis occasionally, but you do need to tell your doctor, especially before fasting labs, pre-surgical panels, hormone workups, or any test being used to diagnose a new problem. Knowing about cannabis use lets a clinician calibrate their interpretation rather than chasing down a false lead or missing a real one.